Atlas Trials

Marginal Zone B Cell Lymphoma

17 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Marginal Zone B Cell Lymphoma

RecordFirmDate
Umbralisib and Rituximab as Initial Therapy for Patients With Follicular Lymphoma and Marginal Zone Lymphoma (NCT03919175)Massachusetts General Hospital2019-09-01
Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders (NCT03314974)Masonic Cancer Center, University of Minnesota2018-03-30
UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep (NCT02722668)Masonic Cancer Center, University of Minnesota2017-05-15
Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies (NCT02991898)Masonic Cancer Center, University of Minnesota2017-02-16
Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases (NCT01962636)Masonic Cancer Center, University of Minnesota2016-12-01
A Study of ME-401 in Subjects With CLL/SLL, FL, and B-cell Non Hodgkin's Lymphoma (NCT02914938)MEI Pharma, Inc.2016-10-01
Bendamustine Plus Rituximab (BR) for Relapsed or Progressive Marginal Zone B-cell Lymphoma (MZBCL) (NCT02433795)Seoul National University Hospital2015-05-01
A Phase II Study of Doxycycline in Relapsed NHL (NCT02086591)University of Rochester2014-03-01
T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies (NCT01163201)Masonic Cancer Center, University of Minnesota2014-01-01
A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers (NCT01460134)Celldex Therapeutics2011-10-01
Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas (NCT00783367)Abramson Cancer Center at Penn Medicine2008-07-01

Track Marginal Zone B Cell Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.